BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21830274)

  • 1. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status.
    Saito S; Kato J; Hiraoka S; Horii J; Suzuki H; Higashi R; Kaji E; Kondo Y; Yamamoto K
    Inflamm Bowel Dis; 2011 Sep; 17(9):1955-65. PubMed ID: 21830274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Tahara T; Hirata I; Nakano N; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
    Inflamm Bowel Dis; 2017 Jan; 23(1):165-173. PubMed ID: 27930411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.
    Torres J; Bao X; Iuga AC; Chen A; Harpaz N; Ullman T; Cohen BL; Pineton de Chambrun G; Asciutti S; Odin JA; Sachar DB; Gaskins HR; Setchell K; Colombel JF; Itzkowitz SH
    Inflamm Bowel Dis; 2013 Feb; 19(2):275-82. PubMed ID: 23348121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
    Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
    Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation status of epithelial-mesenchymal transition (EMT)--related genes is associated with severe clinical phenotypes in ulcerative colitis (UC).
    Tahara T; Shibata T; Okubo M; Ishizuka T; Nakamura M; Nagasaka M; Nakagawa Y; Ohmiya N; Arisawa T; Hirata I
    PLoS One; 2014; 9(10):e107947. PubMed ID: 25303049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.
    Sato F; Shibata D; Harpaz N; Xu Y; Yin J; Mori Y; Wang S; Olaru A; Deacu E; Selaru FM; Kimos MC; Hytiroglou P; Young J; Leggett B; Gazdar AF; Toyooka S; Abraham JM; Meltzer SJ
    Cancer Res; 2002 Dec; 62(23):6820-2. PubMed ID: 12460892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma.
    Toiyama Y; Mizoguchi A; Kimura K; Araki T; Yoshiyama S; Sakaguchi K; Miki C; Kusunoki M
    World J Gastroenterol; 2005 Sep; 11(33):5151-5. PubMed ID: 16127744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.
    Ueda Y; Ando T; Nanjo S; Ushijima T; Sugiyama T
    Dig Dis Sci; 2014 Oct; 59(10):2444-51. PubMed ID: 24825593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease.
    Myers JN; Schäffer MW; Korolkova OY; Williams AD; Gangula PR; M'Koma AE
    Inflamm Bowel Dis; 2014 Sep; 20(9):1530-47. PubMed ID: 25078150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis.
    Tahara T; Inoue N; Hisamatsu T; Kashiwagi K; Takaishi H; Kanai T; Watanabe M; Ishii H; Hibi T
    J Gastroenterol Hepatol; 2005 May; 20(5):710-5. PubMed ID: 15853983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis.
    Hisamatsu T; Watanabe M; Ogata H; Ezaki T; Hozawa S; Ishii H; Kanai T; Hibi T
    Cancer Res; 1999 Dec; 59(23):5927-31. PubMed ID: 10606237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
    Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.